Sampieri CL, Mora M. Gastric cancer research in Mexico: A public health priority. World J Gastroenterol 2014; 20(16): 4491-4502 [PMID: 24782602 DOI: 10.3748/wjg.v20.i16.4491]
Corresponding Author of This Article
Dr. Clara Luz Sampieri, Instituto de Salud Pública, Universidad Veracruzana. Av. Luis Castelazo Ayala, Col. Industrial Ánimas, 91190 Xalapa, Veracruz, México. csampieri@uv.mx
Research Domain of This Article
Oncology
Article-Type of This Article
Topic Highlight
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Apr 28, 2014; 20(16): 4491-4502 Published online Apr 28, 2014. doi: 10.3748/wjg.v20.i16.4491
Table 1 Epidemiological studies of gastric cancer in Mexico
Ref.
Year
Institute of adscription of corresponding author-city
Period of study
Main finding
Source
[23]
2013
IMSSMexico City
NA
There is no association between altitude and the incidence and mortality of gastric cancer
Epidemiological observations
[20]
2012
UVVeracruz, Veracruz
2005-2009
From a total of 1803 cases of digestive tract cancers, gastric cancer was the second most common, with 302 cases (16.76%)
Hospital registries from 5 institutions of Veracruz state
[22]
2012
INCanMexico City
1993-2002
From a total of 767464 cases of digestive system cancers, gastric cancer was the sixth most common with 27659 cases (4%): the third most common in males and seventh in females
Data-base of the histopathological register of malignant neoplasms in Mexico (RHNM)
[21]
2003
INCMNSZMexico City
1978-2001
A total of 90% of the cases were diagnosed in people of age 41 years and moreFrom a total of 11276 cases of digestive system cancers, 3830 (34%) were of gastric cancer
Hospital registries from 6 institutions of Mexico City
[5]
2001
INSPCuernavaca, Morelos
1980-1997
Increase in adjusted mortality rateGender-based differential trend in the magnitude and prematurity of mortality
INEGI
Table 2 Studies of risk and protection factors in gastric cancer in the Mexican population
Ref.
Year
Institute of adscription of corresponding author-city
Main finding
Quantity and type of groups studied
[25]
2012
UVXalapa, Veracruz
Protective effect against gastric cancer: use of mouthwash, refrigeration of food and regular consumption of fruit and vegetablesRisk of gastric cancer: omission of breakfast and failure to refrigerate food
49 gastric cancer162 controls
[27]
2012
INSPCuernavaca, Morelos
Risk of gastric cancer: moderate to high capsaicin consumption synergistically in genetically susceptible individuals (IL-1B-31C allele carriers) infected with more virulent H. pylori (CagA positive) strains
158 gastric cancer317 controls
[28]
2009
INSPCuernavaca, Morelos
Protective effect against gastric cancer: higher intake of cinnamic acids, secoisolariciresinol and coumestrol.Main sources of these molecules: pears, mangos, beans, carrots, squash and legumes
257 gastric cancer478 controls
[29]
2003
INSPCuernavaca, Morelos
Risk of gastric cancer: high consumption of capsaicin (90-250 mg of capsaicin per day, 9-25 jalapeno peppers per day), compared to low-level consumption (0-29.9 mg of capsaicin per day, 0-3 jalapeno peppers per day); this effect is independent of H. pylori status
234 gastric cancer468 controls
[30]
1999
INSPCuernavaca, Morelos
Protective effect against gastric cancer: intake of polyunsaturated fat, fiber and vitamin E, independent of the histological type of the tumor (intestinal or diffuse)Risk of gastric cancer: consumption of saturated fat and cholesterol
Protective effect against gastric cancer: intake of yellow and orange vegetables.Risk of gastric cancer: consumption of fresh and processed meat, dairy products, fish and salty snacks
220 gastric cancer752 controls
[31]
1998
INSPCuernavaca, Morelos
No association with risk of gastric cancer: consumption of foods prepared with corn, wheat or rice
220 gastric cancer752 controls
[32]
1998
INSPCuernavaca, Morelos
Risk of gastric cancer: wine consumption at least 10 glasses per month.No association with risk for gastric cancer: consumption of beer and distilled alcoholic beverages including brandy, rum and tequila
220 gastric cancer752 controls
[33]
1994
INSPCuernavaca, Morelos
Potential risk of gastric cancer: chili pepper consumption
220 gastric cancer 752 controls
Table 3 Studies of Helicobacter pylori in pathologies associated with the development of gastric cancer and gastric cancer in a Mexican population
Ref.
Year
Institute of adscription of corresponding author-city
Main finding
Quantity and type of groups studied
[39]
2013
ISSSTECuliacan, Sinaloa
Association between alcohol consumption and H. pylori infection.No relationship between H. pylori and smoking and coffee consumption
269 H. pylori positive 269 H. pylori negative
[46]
2013
IMSSMexico City
Association between H. pylori and p53 expression and between p53 and intestinal metaplasia
104 patients with no evidence of acute or clinically significant gastric pathology
[41]
2013
INSPCuernavaca, Morelos
IgG2 response to CagA could be used as a novel serological marker to identify patients with H. pylori-associated gastric cancer
Failure to express cag19 and cag24 in vivo in precancerous lesions might serve as a biomarker of the risk of development of gastric cancer
11 gastric cancer10 non atrophic gastritis10 duodenal ulcer
[40]
2011
INSPCuernavaca, Morelos
Vac-A neutralizing antibodies might serve as a biomarker of the risk of development of gastric cancer and duodenal ulcer
90 intestinal metaplasia60 gastric cancer52 duodenal ulcer145 non atrophic gastritis
[43]
2009
UNAMTlalnepantla, Estado de Mexico
Patients with chronic gastritis had a high incidence of infection by H. pylori; 44% of the H. pylori strains may be considered as highly virulent since they possessed two or three of the virulence markers analyzed: vacA s1 cagA babA2
238 chronic gastritis
[50]
2009
IMSSMexico City
30 genes are significantly associated with non-atrophic gastritis, duodenal ulcer, or gastric cancer and may serve as risk biomarkers
10 non atrophic gastritis10 duodenal ulcer9 gastric cancer
[51]
2008
UNAMMexico City
H. pylori is uniformly distributed across the stomach in dyspepsia and has preference for fundus and corpus in gastric cancer.H. pylori genotype diversity across the systematic whole-organ and tumor is remarkable.There is insufficient evidence to support the association of one isolate with a specific disease, due to the multistrain nature of H. pylori
16 gastric cancer14 dyspepsia
[38]
2008
INSPCuernavaca, Morelos
H. pylori infection and CagA are risk markers for intestinal metaplasia. In gastric cancer, prevalence of these risk markers decreases, probably reflecting the fact that infection reduces when advanced atrophy and metaplasia develops
368 non atrophic gastritis126 precancerous lesions65 gastric cancer59 duodenal ulcer
[52]
2004
UANLNuevo Leon, Nuevo Leon
Absence of the HLA-DQA1*0503 allele could be a host risk factor for the development of gastric cancer.Infection with H. pylori CagA+, VacA+ strains represents a significant risk in terms of the development of gastric cancer
22 gastric cancer H. pylori positive8 high grade dysplasia H. pylori positive77 matched controls H. pylori positive
[37]
2004
INSPCuernavaca, Morelos
There is no association between nitrite and ascorbic consumption or interactions of these nutrients with seropositivity to H. pylori CagA+.Seropositivity to H. pylori CagA+ strains may be an independent factor in diffuse gastric cancer
In regions with a high prevalence of chronic atrophic gastritis, serological screening with CagA alone is an effective test for identifying eligible subjects
178 H. pylori positive155 H. pylori CagA+
[45]
1997
INSPCuernavaca, Morelos
H. pylori infection present in 87.2% of cases and 82.5% of controls
109 gastric cancer 177 controls
[44]
1993
INCanMexico City
In a high-risk population, precursor lesions for adenocarcinoma are universally associated with H. pylori infection
245 symptomatic patients
Table 4 Studies of the Epstein-Barr virus in pathologies associated with the development of gastric cancer and gastric cancer in a Mexican population
Ref.
Year
Institute of adscription of corresponding author-city
Main finding
Quantity and type of groups studied
[54]
2013
IMSSMexico City
Co-infection with EBV and H. pylori in pediatric patients is associated with severe gastritis
333 pediatric patients with chronic abdominal pain
[56]
2005
INCanMexico City
EBV was detected in 7.3% of cases, all pertaining to patients > 50 years of age.Among Latin-American countries, Mexico has the lowest frequency of EBV associated gastric carcinoma
330 gastric cancer
[55]
1999
INCanMexico City
EBV is detected in 8.15% cases, six occur in males and five in females
135 gastric cancer
Table 5 Studies of molecular markers for the development of gastric cancer and gastric cancer in a Mexican population
Ref.
Year
Institute of adscription of corresponding author-city
Main finding
Quantity and type of groups studied
[67]
2013
UG Guadalajara, Jalisco
EGFR-R521K and ERBB2-1655V polymorphisms are not suitable as markers for identifying individuals at risk of developing gastric cancer
155 gastric cancer 121 controls 103 general population
[62]
2013
INCMSZ Mexico City
HER2 amplification is restricted to intestinal gastric cancer. HER2 amplification is suitable as a marker for screening gastric cancer histotype
269 gastric cancer
[59]
2010
UV Xalapa, Veracruz
MMP9 expression is enhanced in gastric cancer compared to normal mucosa, and has potential as a molecular marker
6 gastric cancer 11 superficial gastritis
[68]
2010
UNAM Mexico City
Claudin 6, 7, and 9 expression is related to gastric carcinogenesis, and detection of these is a useful prognostic marker in intestinal and diffuse gastric cancer
70 gastric cancer
[60]
2010
IMSS Mexico City
Polymorphisms in TNF and HSP70 have a severity dose-response as risk markers from preneoplastic lesions to gastric cancer, probably because of their association with an intense and sustained inflammatory response
228 non atrophic gastritis 98 intestinal metaplasia 63 gastric cancer 58 duodenal ulcer 132 controls
[63]
2009
INSP Cuernavaca, Morelos
In subjects with high consumption of folate, choline and vitamin B6, and 5,10-methylenetetrahydrofolate reductase (MTHFR) 677 TT genotype, there is a reduction in diffuse gastric risk compared to MTHFR 677 CC + CT carriers. In subjects with low consumption of methionine and MTHFR 677 TT genotype, there is a reduced risk of diffuse gastric cancer compared to MTHFR 677 CC + CT carriers. Carriers of the MTHFR 677 TT genotype with a low consumption of folate have a significantly increased risk of development of intestinal gastric cancer
248 gastric cancer 478 controls
[69]
2007
UANL Monterrey, Nuevo Leon
There is no association between the MTHFR C677T polymorphism and development of gastric cancer
51 gastric cancer 83 controls
[57]
2007
INCMSZ Mexico City
The -160 C/A polymorphism of E-cadherin has a direct effect on the risk of diffuse gastric cancer at a young age
39 gastric cancer younger than 45 years of age 78 controls
[61]
2007
UANL Monterrey, Nuevo Leon
The IL-8-251*A allele could be related to the development of gastric cancer
78 gastric cancer 259 controls
[70]
2006
INSP Cuernavaca, Morelos
High prevalence of MTHFR 677T allele may be a contributor to the high rate of morbidity and mortality in gastric cancer
Identification of the IL-1B-31 promoter polymorphism is a useful marker for the risk of intestinal type gastric cancer in subjects with CagA+H. pylori infection
183 gastric cancer 377 controls
[58]
2005
NYU2 New York, United States
Carrying the Arg/Arg genotype in the codon 72 exon 4 of p53 is associated with risk of development of gastric cancer
65 gastric cancer 182 controls
[72]
2005
UANL Monterrey, Nuevo Leon
Carrying the proinflammatory IL-1B-31*C allele is associated with increased risk of gastric cancer
63 gastric cancer 215 controls
[73]
2004
INCan Mexico City
There is an association of major histocompatibility complex HLA-DQA1*0601 and HLA-DQB1*0501 alleles in gastric cancer compared to chronic gastritis and the healthy condition. These HLA-DQ alleles may be conferring susceptibility for the development of gastric cancer
20 gastric cancer 40 H. pylori-associated chronic gastritis 90 controls
[74]
2003
UANL Monterrey, Nuevo Leon
Carrying the pro-inflammatory IL-1B-31*C allele is associated with an increased risk of gastric cancer and high-grade dysplasia
33 gastric cancer 8 high-grade dysplasia 25 controls
Citation: Sampieri CL, Mora M. Gastric cancer research in Mexico: A public health priority. World J Gastroenterol 2014; 20(16): 4491-4502